Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

5-HO-DPT

From Wikipedia, the free encyclopedia

Pharmaceutical compound
5-HO-DPT
Clinical data
Other names5-Hydroxy-N,N-dipropyltryptamine;N,N-Dipropylserotonin;N,N-Di-n-propylserotonin; DiPS; NDPS
Drug classSerotonin receptor modulator
ATC code
  • None
Identifiers
  • 3-[2-(dipropylamino)ethyl]-1H-indol-5-ol
CAS Number
PubChemCID
ChemSpider
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC16H24N2O
Molar mass260.381 g·mol−1
3D model (JSmol)
  • CCCN(CCC)CCC1=CNC2=C1C=C(C=C2)O
  • InChI=1S/C16H24N2O/c1-3-8-18(9-4-2)10-7-13-12-17-16-6-5-14(19)11-15(13)16/h5-6,11-12,17,19H,3-4,7-10H2,1-2H3
  • Key:CWMOGUBWVJQDSL-UHFFFAOYSA-N

5-HO-DPT, also known as5-hydroxy-N,N-dipropyltryptamine, as well asN,N-dipropylserotonin (DiPS orNDPS), is aserotonin receptor modulator of thetryptamine and5-hydroxytryptamine families.[1] It is theN,N-dipropylderivative ofserotonin (5-hydroxytryptamine; 5-HT).[1]

Pharmacology

[edit]

Pharmacodynamics

[edit]

The drug showsaffinity for theserotonin5-HT1A receptor (Ki = 7.1 nM), the serotonin5-HT1B receptor (Ki = 4,300 nM), and the serotonin5-HT2 receptor (Ki = 1.0–450 nM).[1] 5-HO-DPT was not tested itself, but itsO-methylether5-MeO-DPT fully substituted for thepsychedelic drugDOM in rodentdrug discrimination tests and partially substituted for8-OH-DPAT in these tests followed by behavioral disruption at higher doses.[1]

5-Hydroxytryptamines likebufotenin (5-HO-DMT) are known to behydrophilic andperipherally selective, in turn resulting in difficulty crossing theblood–brain barrier and exertingcentral effects.[1] However, 5-HO-DPT is notable in having much greaterlipophilicity in comparison to bufotenin owing to itspropyl groups (predictedlog P = 3.0 and 1.2, respectively).[2][3]

Chemistry

[edit]

Analogues

[edit]

Analogues of 5-HO-DPT includedipropyltryptamine (DPT),4-HO-DPT (deprocin),4-AcO-DPT (depracetin),5-MeO-DPT,bufotenin (5-HO-DMT),5-HO-MET,5-HO-DET, and5-HO-DiPT, among others.

History

[edit]

5-HO-DPT was first described in thescientific literature byRichard Glennon and colleagues by 1988.[1]

See also

[edit]

References

[edit]
  1. ^abcdefGlennon RA, Titeler M, Lyon RA, Slusher RM (April 1988). "N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin".Journal of Medicinal Chemistry.31 (4):867–870.doi:10.1021/jm00399a031.PMID 2965244.
  2. ^"N,N-Di-n-propylserotonin".PubChem. Retrieved18 June 2025.
  3. ^"Bufotenin".PubChem. U.S. National Library of Medicine. Retrieved8 June 2025.

External links

[edit]
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
α-Ketotryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=5-HO-DPT&oldid=1331362178"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp